Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3038 |
|
Actual shortage: | 231 (8%) | |
Anticipated shortage: | 14 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2784 (92%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (12%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-VARENICLINE | 1MG | TABLET | Resolved | 2023-04-21 | 2023-04-27 | 190014 |
APO-VARENICLINE | 1MG | TABLET | Resolved | 2023-05-12 | 2023-06-02 | 192364 |
APO-TERAZOSIN | 1MG | TABLET | Resolved | 2023-06-16 | 2024-04-02 | 195250 |
APO-PRUCALOPRIDE | 1MG | TABLET | Resolved | 2023-10-06 | 2023-12-01 | 206557 |
APO-GUANFACINE XR | 1MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-10-06 | 2024-01-12 | 206579 |
APO-HYDROMORPHONE | 1MG | TABLET | Resolved | 2023-10-27 | 2023-12-15 | 208397 |
APO-GUANFACINE XR | 1MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-11-06 | 2024-01-12 | 209339 |
APO-VARENICLINE | 1MG | TABLET | Resolved | 2023-11-06 | 2023-12-01 | 209366 |
APO-WARFARIN | 1MG | TABLET | Resolved | 2023-11-17 | 2023-12-22 | 210698 |
APO-RASAGILINE | 1MG | TABLET | Resolved | 2023-11-17 | 2023-12-08 | 210743 |
APO-PRUCALOPRIDE | 1MG | TABLET | Resolved | 2024-02-16 | 2024-03-29 | 219834 |
APO-WARFARIN | 1MG | TABLET | Resolved | 2024-04-05 | 2024-05-15 | 224589 |
APO-ANASTROZOLE | 1MG | TABLET | Anticipated shortage | 2024-04-12 | 2024-04-12 | 225101 |
APO-VARENICLINE | 1MG | TABLET | Actual shortage | 2024-04-19 | 2024-05-17 | 225764 |
APO-WARFARIN | 1MG | TABLET | Resolved | 2024-04-19 | 2024-05-15 | 225782 |
APO-VARENICLINE | 1MG 0.5MG | TABLET KIT | Actual shortage | 2021-11-29 | 2021-11-29 | 150175 |
APO-SUCRALFATE - TAB 1G | 1G | TABLET | Resolved | 2017-09-06 | 2018-09-11 | 21096 |
APO-CEFEPIME | 1G | POWDER FOR SOLUTION | Resolved | 2019-03-27 | 2019-03-29 | 79574 |
APO-SUCRALFATE - TAB 1G | 1G | TABLET | Resolved | 2020-01-22 | 2020-03-09 | 103923 |
APO-CEFEPIME | 1G | POWDER FOR SOLUTION | Resolved | 2020-05-13 | 2020-05-19 | 114937 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-HYDROMORPHONE CR | 9MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110977 |
APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
APO-METFORMIN | 850MG | TABLET | Discontinued | 2018-02-23 | 2019-06-12 | 40778 |
APO-METFORMIN | 850MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40796 |
APO-ASA LD | 81MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60252 |
COATED DAILY LOW DOSE ASA 81 MG | 81MG | TABLET (DELAYED-RELEASE) | Discontinued | 2019-01-03 | 2019-01-04 | 71083 |
APO-FUROSEMIDE | 80MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4719 |
APO-SOTALOL | 80MG | TABLET | Discontinued | 2017-03-31 | 2018-12-07 | 4936 |
APO-TELMISARTAN | 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40817 |
APO-TELMISARTAN | 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40820 |
APO-ATORVASTATIN | 80MG | TABLET | Discontinued | 2018-09-07 | 2018-12-29 | 60285 |
APO-GLICLAZIDE | 80MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60512 |
APO-DICLO SR | 75MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2017-03-31 | 2017-03-31 | 4915 |
APO-IRBESARTAN | 75MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71231 |
APO-DIPYRIDAMOLE | 75MG | TABLET | Discontinued | 2019-12-20 | 2019-12-21 | 101880 |
APO-FENTANYL MATRIX | 75MCG | PATCH | Discontinued | 2018-09-07 | 2018-09-15 | 60497 |
APO-CIPROFLOX | 750MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60388 |
APO-MELOXICAM | 7.5MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60612 |
APO-BROMAZEPAM | 6MG | TABLET | Discontinued | 2018-09-07 | 2018-10-19 | 60310 |